A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics
|
|||||
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds 
A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms. . . . → Read More: Univ. Spin-Off Developing A.I.-Boosted Heart Monitor 
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund  Comments are closed  Finance  biomedical, engineering, entrepreneurs, equity, Europe, investment, life sciences, physical sciences, physics, U.K., university, venture capital 
A lab in the U.K. developed a system for discovering new therapies that identify therapy targets linked to enzymes, some found in neurodegenerative diseases, previously considered too difficult to address. . . . → Read More: Drug Discovery System Designed to Identify Difficult Targets Comments are closed New products biomedical, biotechnology, entrepreneurs, Europe, life sciences, patent, pharmaceuticals, preclinical, U.K. 
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, clinical trials, equity, Europe, genomics, investment, life sciences, medical device, pharmaceuticals, U.K. The health care industry is taking advantage of lower-cost, access-anywhere web-based services and vast amounts of storage for their enormous amounts of patient records and other files. . . . → Read More: On Cloud Nine as Remote Computing Transforms Health Care Industry 
A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood. . . . → Read More: More Damage Detected from Crispr-Cas9 Edits Comments are closed Regulations biomedical, biotechnology, Europe, genomics, life sciences, patent, pharmaceuticals, stem cells, U.K. 
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled One comment - (Comments are closed) Finance biomedical, entrepreneurs, equity, Europe, investment, life sciences, U.K., venture capital 
Researchers in the U.S. and the Netherlands found ingredients in over-the-counter products to control fleas and ticks in house pets can also help prevent infectious diseases in humans spread by mosquitoes. . . . → Read More: Pet Health Ingredients Shown Effective Against Mosquito-Borne Diseases Comments are closed Joint ventures/collaborations, New products Africa, biomedical, Europe, life sciences, mathematics, pharmaceuticals, U.K., university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
